{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T08:38:40Z","timestamp":1786523920771,"version":"build-2736575974"},"reference-count":23,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Clin. Med.","JCM"],"abstract":"<jats:p>Background: Balkan nephropathy (BEN), caused by chronic dietary exposure to aristolochic acid (AA), is a tubulointerstitial kidney disease strongly associated with upper-tract urothelial carcinoma (UTUC). Patient and graft survival, the cumulative incidence and timing of post-transplant UTUC, and the burden of non-urothelial malignancy after kidney transplantation remain poorly defined. Methods: We retrospectively analyzed all patients with BEN as the primary cause of end-stage kidney disease transplanted at University Hospital Center Zagreb between October 1973 and December 2023. Outcomes included patient and graft survival, the incidence and timing of post-transplant UTUC, and burden of non-urothelial malignancies. Results: Of 2282 kidney transplants performed in the study period, 44 (2%) were in patients with BEN. The median age at transplantation was 56 years, and the median dialysis vintage was 3.7 years. After 10 years (median) of follow up, among 34 patients with adequate follow-up, 16 (47%) developed a de novo malignancy: eight (24%) UTUC, one renal cell carcinoma, four other solid tumors, and three hematological. UTUC was diagnosed between 6 months and 15 years post-transplant (median 7 years); five of eight patients died within one year of diagnosis. Five- and ten-year patient survival rates were 82% and 54.5%. Conclusions: Kidney transplantation in patients with BEN carries a lifelong cancer risk dominated by UTUC. Prophylactic bilateral nephroureterectomy should be the default management strategy when feasible, with lifelong surveillance extending beyond the urothelium.<\/jats:p>","DOI":"10.3390\/jcm15166226","type":"journal-article","created":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T07:57:26Z","timestamp":1786521446000},"page":"6226","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cancer Incidence and Outcomes After Kidney Transplantation in Balkan Nephropathy Patients"],"prefix":"10.3390","volume":"15","author":[{"given":"Matko","family":"Prtori\u0107","sequence":"first","affiliation":[{"name":"School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2487-6878","authenticated-orcid":false,"given":"Armin","family":"Ati\u0107","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Center Zagreb, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2546-4632","authenticated-orcid":false,"given":"Bojan","family":"Jelakovi\u0107","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"},{"name":"Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Center Zagreb, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017deljko","family":"Ka\u0161telan","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"},{"name":"Urology Clinic, University Hospital Center Zagreb, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0221-2758","authenticated-orcid":false,"given":"Nikolina","family":"Ba\u0161i\u0107-Juki\u0107","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Zagreb, 10000 Zagreb, Croatia"},{"name":"Department of Nephrology, Arterial Hypertension, Dialysis and Transplantation, University Hospital Center Zagreb, 10000 Zagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.semnephrol.2019.02.007","article-title":"Balkan endemic nephropathy and the causative role of aristolochic acid","volume":"39","author":"Dika","year":"2019","journal-title":"Semin. Nephrol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/ki.2011.371","article-title":"Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid","volume":"81","author":"Miller","year":"2012","journal-title":"Kidney Int."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/ki.1994.220","article-title":"Chinese herbs nephropathy: A clue to Balkan endemic nephropathy?","volume":"45","author":"Cosyns","year":"1994","journal-title":"Kidney Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0278-6915(92)90032-G","article-title":"Clinical features of Balkan endemic nephropathy","volume":"30","year":"1992","journal-title":"Food Chem. Toxicol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"12129","DOI":"10.1073\/pnas.0701248104","article-title":"Aristolochic acid and the etiology of endemic (Balkan) nephropathy","volume":"104","author":"Grollman","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1002\/ijc.29338","article-title":"Renal cell carcinomas of chronic kidney disease patients harbor the mutational signature of carcinogenic aristolochic acid","volume":"136","author":"Castells","year":"2015","journal-title":"Int. J. Cancer"},{"key":"ref_7","first-page":"115","article-title":"Molecular profiles and urinary biomarkers of upper tract urothelial carcinomas associated with aristolochic acid exposure","volume":"149","author":"Ardin","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/ndt\/gft384","article-title":"Consensus statement on screening, diagnosis, classification and treatment of endemic (Balkan) nephropathy","volume":"29","author":"Nortier","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.transproceed.2006.11.019","article-title":"Renal transplantation in patients with Balkan endemic nephropathy","volume":"39","author":"Kes","year":"2007","journal-title":"Transplant. Proc."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Rukavina, L., \u017div\u010di\u0107-\u0106osi\u0107, S., Marki\u0107, D., \u0160temberger, C., Ljubi\u0107, J., Rukavina, T., \u0160panjol, J., Brzi\u0107, I., Samard\u017ei\u0107, J., and Domislovi\u0107, M. (2026). Long-term outcome of kidney transplant patients from rural farming areas with Balkan nephropathy: A single-centre report. J. Clin. Med., 15.","DOI":"10.3390\/jcm15072558"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.urology.2015.10.031","article-title":"Urothelial cancer in renal transplant recipients: Incidence, risk factors, and oncological outcome","volume":"88","author":"Ardelt","year":"2016","journal-title":"Urology"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/ncpuro1019","article-title":"Balkan endemic nephropathy and associated urothelial cancer","volume":"5","author":"Stefanovic","year":"2008","journal-title":"Nat. Clin. Pract. Urol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/TP.0000000000000941","article-title":"Long-term outcome of kidney recipients transplanted for aristolochic acid nephropathy","volume":"100","author":"Kanaan","year":"2016","journal-title":"Transplantation"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1053\/j.ajkd.2007.11.015","article-title":"Late onset of bladder urothelial carcinoma after kidney transplantation for end-stage aristolochic acid nephropathy: A case series with 15-year follow-up","volume":"51","author":"Lemy","year":"2008","journal-title":"Am. J. Kidney Dis."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Medunjanin, D., Sonicki, Z., Vena, J.E., Cvitkovic, A., and Robb, S.W. (2019). Geographic distribution and risk of upper urothelial carcinomas in Croatia, 2001\u20132011. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-6160-9"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Shan, H., Tian, W., Hong, Y., Xu, B., Wang, C., Yu, B., and Wang, X. (2020). Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma complicated with aristolochic acid nephropathy after radical nephroureterectomy. BMC Complement. Med. Ther., 20.","DOI":"10.1186\/s12906-020-2861-5"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"786.e9","DOI":"10.1016\/j.urolonc.2021.03.016","article-title":"Prognostic value of Balkan endemic nephropathy and gender on upper tract urothelial carcinoma outcomes after radical nephroureterectomy: A cohort study","volume":"39","author":"Milojevic","year":"2021","journal-title":"Urol. Oncol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1158\/1055-9965.EPI-16-0219","article-title":"Aristolochic acid in the etiology of renal cell carcinoma","volume":"25","author":"Hoang","year":"2016","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"7118","DOI":"10.1038\/s41598-025-91594-9","article-title":"SFRP2 mediates Epstein-Barr virus and bladder cancer risk: A Mendelian randomization study and colocalization analysis","volume":"15","author":"Li","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1308\/rcsann.2020.0138","article-title":"Can Epstein-Barr virus play a role in upper urinary tract urothelial carcinomas?","volume":"102","author":"Dere","year":"2020","journal-title":"Ann. R. Coll. Surg. Engl."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1464-410X.2010.09474.x","article-title":"Epstein-Barr virus DNA load in tumour tissues correlates with poor differentiation status in non-muscle invasive urothelial carcinomas","volume":"107","author":"Chuang","year":"2011","journal-title":"BJU Int."},{"key":"ref_22","first-page":"15","article-title":"Sporadic Balkan endemic nephropathy beyond the known regions of BEN","volume":"4","author":"Pejcic","year":"2006","journal-title":"BANTAO J."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1159\/000094816","article-title":"Upper urothelial tumors in emigrants from Balkan endemic nephropathy areas in Serbia","volume":"77","author":"Djokic","year":"2006","journal-title":"Urol. Int."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6226\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T08:21:29Z","timestamp":1786522889000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/16\/6226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,12]]},"references-count":23,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["jcm15166226"],"URL":"https:\/\/doi.org\/10.3390\/jcm15166226","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,12]]}}}